Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04157088
Title Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC) (DaroAcT)
Acronym DaroAcT
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors Bayer
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.